• OPEN AN ACCOUNT
Indian Indices
Nifty
19,742.35 -159.05
(-0.80%)
Sensex
66,150.16 -80.08
( -0.12%)
Bank Nifty
44,623.85 -760.75
( -1.68%)
Nifty IT
32,919.95 -29.25
( -0.09%)
Global Indices
Nasdaq
13,223.99 -245.14
(-1.82%)
Dow Jones
34,070.42 -370.46
(-1.08%)
Hang Seng
17,655.41 -230.19
(-1.29%)
Nikkei 225
32,402.41 -168.62
(-0.52%)
Forex
USD-INR
83.10 -0.18
(-0.21%)
EUR-INR
88.83 -0.16
(-0.18%)
GBP-INR
102.82 -0.35
(-0.34%)
JPY-INR
0.56 0.00
(-0.32%)

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500124
INE089A01023
1235.1963026
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DRREDDY
25.21
94594.48
EPS(TTM)
Face Value()
Div & Yield %
225
5
0.7
 

kcd industries india ltd
KCD Industries India Ltd - Announcement under Regulation 30 (LODR)-Newspaper Publication
Feb 27,2023
Pursuant to Regulation 47 the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby enclose the Public Announcement issued in Business Standard (All edition) Jansatta (All edition) and Marathi Newspaper (Regional edition) on 26th February 2023 regarding approval of the Draft Letter of Offer (DLOF) for raising of funds through issuance and allotment of Equity Shares to the eligible equity shareholders of the Company on a Rights basis. The Draft Letter of Offer has been filed with BSE on 24th February 2023 and is available on the website of the Company for the reference of the investors. You are requested to take the above cited information on your records.